ADAPTHEALTH CORP (AHCO) Stock Price, Forecast & Analysis
USA - NASDAQ:AHCO - US00653Q1022 - Common Stock
AHCO Key Statistics, Chart & Performance
The current stock price of AHCO is 8.99 USD. In the past month the price decreased by -1.1%. In the past year, price decreased by -14.38%.
AHCO Latest News, Press Relases and Analysis
AHCO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 24.23 | 100.91B | ||
| COR | CENCORA INC | 21.81 | 65.49B | ||
| CAH | CARDINAL HEALTH INC | 21.41 | 45.32B | ||
| HSIC | HENRY SCHEIN INC | 13.56 | 7.66B | ||
| AHG | AKSO HEALTH GROUP | N/A | 889.76M | ||
| OMI | OWENS & MINOR INC | 2.72 | 306.64M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 63.91M | ||
| ATPC | AGAPE ATP CORP | N/A | 60.01M | ||
| COSM | COSMOS HEALTH INC | N/A | 24.47M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 2.44M | ||
| POM | POMDOCTOR LTD - ADR | N/A | 640.76M |
Related stock screener links
About AHCO
Company Profile
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Conshohocken, Pennsylvania and currently employs 10,500 full-time employees. The company went IPO on 2018-02-21. The firm provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company operates in 50 states through its network of over 670 locations in 47 states.
Company Info
ADAPTHEALTH CORP
555 East North Lane, Suite 5075
Conshohocken PENNSYLVANIA 19462 US
CEO: Luke McGee
Employees: 10500
Phone: 16104244515
ADAPTHEALTH CORP / AHCO FAQ
What does ADAPTHEALTH CORP do?
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Conshohocken, Pennsylvania and currently employs 10,500 full-time employees. The company went IPO on 2018-02-21. The firm provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company operates in 50 states through its network of over 670 locations in 47 states.
Can you provide the latest stock price for ADAPTHEALTH CORP?
The current stock price of AHCO is 8.99 USD. The price increased by 0.45% in the last trading session.
Does ADAPTHEALTH CORP pay dividends?
AHCO does not pay a dividend.
How is the ChartMill rating for ADAPTHEALTH CORP?
AHCO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What sector and industry does ADAPTHEALTH CORP belong to?
ADAPTHEALTH CORP (AHCO) operates in the Health Care sector and the Health Care Providers & Services industry.
Should I buy AHCO stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AHCO.
AHCO Technical Analysis
AHCO Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AHCO. There are concerns on the financial health of AHCO while its profitability can be described as average.
AHCO Financial Highlights
Over the last trailing twelve months AHCO reported a non-GAAP Earnings per Share(EPS) of 0.31. The EPS increased by 122.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.29% | ||
| ROA | 1.66% | ||
| ROE | 4.73% | ||
| Debt/Equity | 1.27 |
AHCO Forecast & Estimates
14 analysts have analysed AHCO and the average price target is 13.26 USD. This implies a price increase of 47.5% is expected in the next year compared to the current price of 8.99.
For the next year, analysts expect an EPS growth of 34.3% and a revenue growth -0.24% for AHCO